ACT CIPROFLOXACIN
TEVA CANADA LIMITED
Quick answers
Is there a shortage of ACT CIPROFLOXACIN in Canada?
No. There is no current shortage of ACT CIPROFLOXACIN 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
SANDOZ CIPROFLOXACIN
SANDOZ CANADA INCORPORATED
JAMP-CIPROFLOXACIN
JAMP PHARMA CORPORATION
PRO-CIPROFLOXACIN
PRO DOC LIMITEE
AURO-CIPROFLOXACIN
AURO PHARMA INC
Other Products
RIVA-CIPROFLOXACIN
LABORATOIRE RIVA INC.
CIPROFLOXACIN
SANIS HEALTH INC
DIN
02247339
Strength
250MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
See all CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
750MG · DIN 02247341
500MG · DIN 02247340
75MG · DIN 02303027
180MG · DIN 02370638
300MG · DIN 02370654
120MG · DIN 02370611